NCT01558570 Intracellular Tight Junction Permeability in Schizophrenia: Focus on Zonulin Status COMPLETED Phase N/A
NCT01556763 Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Schizophrenia Status COMPLETED Phase PHASE1
NCT01555814 Optimization of Treatment and Management of Schizophrenia in Europe (OPTIMISE): Substudy Site Copenhagen Status COMPLETED Phase NA
NCT01555697 Biomarker Strategies for Medication-Enhanced Cognitive Training in Schizophrenia Status COMPLETED Phase PHASE1/PHASE2
NCT01552772 Safety and Tolerability Trial of Aripiprazole IM Depot Treatment in Adult Subjects With Schizophrenia Stabilized on Oral Antipsychotics Other Than Aripiprazole Status COMPLETED Phase PHASE1
NCT01551979 Therapeutic Efficacy of Transcranial Magnetic Stimulation in Schizophrenia Status COMPLETED Phase NA
NCT01550666 Treatment Development Targeting Severe and Persistent Negative Symptoms Status COMPLETED Phase NA
NCT01548612 Add-on Sodium Nitroprusside to Treatment as Usual in Schizophrenia Status COMPLETED Phase PHASE2
NCT01547026 Self-regulation Strategies to Improve Exercise Behavior Among Schizophrenic Patients Status COMPLETED Phase NA
NCT01545999 Paired Associative Stimulation in the Dorsolateral Prefrontal Cortex in Patients With Schizophrenia Status ACTIVE_NOT_RECRUITING Phase NA
NCT01545310 A Positron Emission Tomography Study of SLV354 in Healthy Subjects and Subjects With Schizophrenia Status COMPLETED Phase PHASE1
NCT01544608 Observe Real-life Allocation of Atypical Antipsychotics in the Acute Inpatient Management of Schizophrenia Status COMPLETED Phase N/A
NCT01542229 PTSD (PostTraumatic Stress Disorder) Services for Veterans With SMI (Severe Mental Illness) Status COMPLETED Phase NA
NCT01541371 A Study of Flexibly Dosed Paliperidone Extended Release Tablets in Participants With Schizophrenia Status COMPLETED Phase PHASE3
NCT01534936 Atypical Antipsychotics in the Treatment of Affective Symptoms of Schizophrenia in Hungary Status COMPLETED Phase N/A
NCT01529515 A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With Schizophrenia Status COMPLETED Phase PHASE3
NCT01527305 A Study to Evaluate the Effectiveness and Safety of Paliperidone Palmitate in Subjects With Acute Schizophrenia Status COMPLETED Phase PHASE4
NCT01526395 Decreasing the Use of Unmodified Electroconvulsive Therapy (ECT) in an Indian Hospital Status COMPLETED Phase NA